(Q38416111)

2 September 2017

Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure (English)

1 reference

2 September 2017

1 reference

Renske Fles

1

1 reference

2 September 2017

Wilhelmina E Hoogendoorn

2

1 reference

2 September 2017

Inge Platteel

3

1 reference

2 September 2017

Caroline E Scheerman

4

1 reference

2 September 2017

Gerie de Leeuw-Mantel

5

1 reference

2 September 2017

Marian J E Mourits

6

1 reference

2 September 2017

Harry Hollema

7

1 reference

2 September 2017

Flora E van Leeuwen

8

1 reference

2 September 2017

Hester H van Boven

9

1 reference

2 September 2017

Petra M Nederlof

10

1 reference

2 September 2017

1 August 2010

1 reference

Genes, Chromosomes and Cancer

2 September 2017

1 reference

2 September 2017

49

1 reference

2 September 2017

8

1 reference

2 September 2017

699-710

1 reference

Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors

2 September 2017

1 reference

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

21 January 2018

1 reference

7 January 2021

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

7 January 2021

Tamoxifen therapy for breast cancer and endometrial cancer risk.

1 reference

7 January 2021

Overview of the main outcomes in breast-cancer prevention trials

1 reference

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

7 January 2021

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

1 reference

7 January 2021

Validation of tissue microarray technology in endometrioid cancer of the endometrium

1 reference

7 January 2021

Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women

1 reference

7 January 2021

Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer

1 reference

7 January 2021

Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material

1 reference

7 January 2021

Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point

1 reference

7 January 2021

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

1 reference

7 January 2021

Molecular carcinogenesis of endometrial cancer

1 reference

7 January 2021

Genomic aberrations in carcinomas of the uterine corpus

1 reference

7 January 2021

Genome-wide analysis of deoxyribonucleic acid in endometrial cancer using comparative genomic hybridization microarrays.

1 reference

7 January 2021

A statistical approach for array CGH data analysis

1 reference

7 January 2021

Array comparative genomic hybridization with cyanin cis-platinum-labeled DNAs.

1 reference

7 January 2021

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

7 January 2021

Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.

1 reference

7 January 2021

Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study

1 reference

7 January 2021

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis

1 reference

7 January 2021

Tamoxifen: important considerations of a multi-functional compound with organ-specific properties

1 reference

7 January 2021

Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization

1 reference

7 January 2021

Genetic aberrations detected by comparative genomic hybridization predict outcome in patients with endometrioid carcinoma

1 reference

7 January 2021

Frequent gains on chromosome arms 1q and/or 8q in human endometrial cancer

1 reference

7 January 2021

Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study

1 reference

7 January 2021

A multiplex PCR predictor for aCGH success of FFPE samples

1 reference

7 January 2021

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

7 January 2021

Mechanisms of action of antiestrogens.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20781

1 reference

2 September 2017

1 reference